pyrimidoindole series

The pyrimidoindole series is a collection of small molecule compounds developed by RejuvenRx, currently in the preclinical stage for the treatment of various aging-related diseases. These molecules are designed to target the fundamental biological processes of aging to promote healthy longevity and tissue regeneration. The series originates from research into small molecules that can expand hematopoietic stem cells and modulate cellular states, a field in which the company's founders have significant expertise. While specific molecular targets for this series have not been publicly detailed by the company, the pyrimidoindole chemical scaffold is associated with potent regenerative properties and the modulation of epigenetic complexes. RejuvenRx is leveraging this series to develop therapies that address the underlying drivers of age-related decline.